Caitong International Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Buy
884
+864
+4,320% +$20.2K ﹤0.01% 953
2026
Q1
$280 Buy
20
+19
+1,900% +$256 ﹤0.01% 1810
2025
Q4
$11 Sell
1
-1,439
-100% -$16.5K ﹤0.01% 1806
2025
Q3
$16.6K Buy
1,440
+1,233
+596% +$14.4K 0.01% 803
2025
Q2
$2.53K Buy
207
+146
+239% +$1.84K ﹤0.01% 1305
2025
Q1
$874 Buy
+61
New +$952 ﹤0.01% 1612

Other funds holding AVNS

Caitong International Asset Management's AVNS Position: Q2 2026 in Review

Caitong International Asset Management increased its Avanos Medical (AVNS) stake by 4,320% in Q2 2026, buying an estimated $20.2K and bringing the position to 884 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Caitong International Asset Management first reported a position in AVNS in Q1 2025 and has held it in 6 quarters since. 130 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Caitong International Asset Management held 884 shares of Avanos Medical worth $22K as of Q2 2026.
  • Caitong International Asset Management bought 864 Avanos Medical shares in Q2 2026, an estimated $20.2K.
  • Avanos Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #953 holding.
  • Caitong International Asset Management first reported a position in Avanos Medical in Q1 2025 and has held it in 6 quarters since.
  • 130 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.